Funding Organization: National Institutes of Health (NIH)
Total Funding Amount: Estimated at $150,000 per year
Duration: Total project period may not exceed 3 years
Primary Objective: To support exploratory research projects focused on innovative technologies for cancer research
Key Stakeholders: National Cancer Institute (NCI), higher education institutions, nonprofits, government entities
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local governments, state governments, and tribal governments.
Non-domestic (non-U.S.) entities are eligible to apply.
Open to U.S. and non-domestic entities.
Foreign components are allowed.
Focus on early-stage development of innovative molecular or cellular analysis technologies.
Projects must demonstrate a high degree of technical innovation.
Applications must include quantitative performance measures.
Application budgets are limited to $150,000 per year (direct costs).
No cost-sharing is required.
Application due date: October 3, 2025.
Open date for submissions: March 4, 2025.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
A letter of intent is encouraged but not required.
Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise.
Applications will undergo scientific peer review by appropriate Scientific Review Groups.
Projects must focus on developing novel capabilities rather than pursuing specific discoveries.
Applications proposing traditional biological-hypothesis driven research will not be reviewed.
Demonstrating a clear potential impact on cancer research or clinical practice.
Submitting applications that do not comply with the application instructions.